CLINICAL OUTCOMES OF HAEMORRHOIDAL ARTERY EMBOLIZATION FOR GRADE II AND ABOVE HAEMORRHOIDAL DISEASE: A PROSPECTIVE STUDY COMPARING NBCA AND PVA PARTICLES

Authors: Dr. Abhishek Saha*, Dr. Abhisek Gupta, Dr. Mitesh Gupta, Dr. Manish Shaw, Dr. Hima Pendharkar, Dr. Praveen Singhal

DOI:

DOI: DOI.ORG/10.59551/IJHMP/25832069/2026.7.3/4.116

ABSTRACT:

Background: Haemorrhoidal artery embolization (HAE) is a minimally invasive, vascular-targeted treatment intended to reduce arterial inflow to haemorrhoidal tissue while preserving anorectal anatomy. Evidence comparing embolic materials remains limited.

Objective: To assess the clinical outcomes of HAE in patients with Grade II or higher haemorrhoidal disease and compare outcomes following embolization with N-butyl cyanoacrylate (NBCA) and polyvinyl alcohol (PVA) particles.

Methods: This prospective study was conducted at NIMS Hospital and included 30 patients aged 18–65 years with Grade II–IV haemorrhoidal disease and rectal bleeding. Fifteen patients received NBCA and 15 received PVA particles. The source study gives conflicting descriptions of group allocation (operator discretion versus computer-generated stratified randomization), which must be resolved before the design can be accurately classified. Outcomes included symptom severity, quality of life (QoL), post-procedural pain, and recurrence at six months.

Results: The mean age was 41.43 ± 12.26 years and 56.7% of participants were male. Grade III disease was most common (50.0%), followed by Grade II (40.0%) and Grade IV (10.0%). At baseline, the mean symptom severity score was 7.43 ± 1.19, QoL score was 43.17 ± 10.02, haemorrhoidal bleeding score was 4.50 ± 1.14, and haemoglobin was 11.11 ± 1.38 g/dL. Mean pain score at six hours was 2.73 ± 1.05. At six months, the mean symptom severity score was 0.80 ± 0.81 and QoL score was 81.50 ± 7.49. Recurrence occurred in 3/30 patients (10.0%). Outcomes were numerically more favourable with NBCA than PVA: six-month symptom severity scores were 0.67 ± 0.72 versus 0.93 ± 0.88, QoL scores were 82.3 ± 7.1 versus 80.7 ± 7.9, and recurrence was 6.7% versus 13.3%, respectively.

Conclusion: HAE was associated with improved symptom scores and QoL, low early post-procedural pain, and a 10% recurrence rate at six months in this small cohort. Both embolic materials showed favourable outcomes; numerical differences favouring NBCA should be interpreted cautiously because inferential comparisons were not reported.

KEYWORDS: Haemorrhoidal Disease, Haemorrhoidal Artery Embolization, N-butyl Cyanoacrylate, Polyvinyl Alcohol, Quality of Life, Recurrence.

Full Text Article (PDF)